SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CNSI Cambridge Neuroscience
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: TheSlowLane who wrote (321)1/2/1998 11:07:00 AM
From: NeuroInvestment  Read Replies (1) of 675
 
Could be....though there are plenty of folks trying to figure out which 1997 losers can turn around fastest, and that type of market screen does highlight CNSI. COCN and NTII also are price-ravaged small neuro companies with a notable upswing today, which would support theory #1. There may also be rumors re: buyout that I am not privy to... I had a conversation 2-3 weeks ago with the CEO of a Big Pharma company, looking to expand their neuro portfolio, who acknowledged having been intrigued by CNSI, though he put it in past tense (though he would hardly have wanted to make a present-tense interest known to me). He is surely not alone, there are numerous big and mid-cap companies looking for the cheapest way to expand their pipelines. Analysts following Big Pharma firms may be placing some bets as to acquisition candidates. NeuroInvestment
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News